The historic “prohibition” against the use of testosterone therapy in men with a history of prostate cancer is based on a model that assumes that the androgen sensitivity of prostate cancer extends throughout the range of testosterone concentrations.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: androgen sensitivity, testosterone therapy | 2 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site
